<SEC-DOCUMENT>0000849146-19-000010.txt : 20190110
<SEC-HEADER>0000849146-19-000010.hdr.sgml : 20190110
<ACCEPTANCE-DATETIME>20190110160557
ACCESSION NUMBER:		0000849146-19-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20190110
DATE AS OF CHANGE:		20190110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		19520312

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kjan102019.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s85c7ae6fa5224baf814f0fb37270cb3c"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): January 10, 2019</font></div><div style="line-height:120%;padding-bottom:9px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:2px;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">LIFEVANTAGE CORPORATION</font></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:9px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:31%;"></td><td style="width:7%;"></td><td style="width:27%;"></td><td style="width:7%;"></td><td style="width:28%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9785 S. Monroe Street, Suite 400, Sandy, UT 84070</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices and Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801) 432-9000</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:11%;"></td><td style="width:89%;"></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company&#160;&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.02.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations and Financial Condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On&#160;January 9, 2019, LifeVantage Corporation (the &#8220;Company&#8221;) issued a press release announcing its preliminary unaudited revenue results for the three and six months ended&#160;December 31, 2018. A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;5.02. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 8, 2019, the Board of Directors (the &#8220;Board&#8221;) of the Company approved an amendment and restatement of the employment agreement (the &#8220;Restated Agreement&#8221;) between the Company and the Company&#8217;s President and Chief Executive Officer, Darren Jensen.  The Board, on the recommendation of its Compensation Committee, concluded that it was appropriate at this time to update Mr. Jensen&#8217;s employment agreement and restructure his compensation arrangements including to strategically align his continued commitment to the Company, support his professional development, recognize and reward recent Company achievements including stock price growth and assure a smooth and effective future management succession process.  The Restated Agreement supersedes in its entirety Mr. Jensen's prior employment agreement dated effective as of December 6, 2016 (the "Prior Agreement").  </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Agreement amends the revenue-based cash incentive awards that Mr. Jensen was eligible to earn under the Prior Agreement to:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:98px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:74px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Replace three separate annual product-line incentive awards with a single net revenue-based annual award having a value equal to two percent (2%) of the increase in net revenue achieved for the applicable fiscal year relative to that prior fiscal year in which the Company&#8217;s net revenue achievement was the greatest.  The bonus amount reduction feature that applied under the Prior Agreement to the product line incentive awards in connection with a decrease in year-over-year gross profit margin continues to apply to this restructured annual net revenue award. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:98px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:74px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Permit the Company to satisfy its obligations with respect to the above net revenue-based award, as well as with respect to existing incentive awards tied to the Company&#8217;s achievement of specified annual revenue milestones, by granting Mr. Jensen restricted stock units (RSUs) having a grant date value equal to 105% of the earned value of the incentive award.  If the Company determines to satisfy its obligations earned by Mr. Jensen by granting him RSUs, such awards would have a continuing service requirement for 12 months following the grant date.   </font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Board approved the grant to Mr. Jensen on January 8, 2019 of his fiscal year 2019 equity awards, having the same structure as awards granted to the Company&#8217;s other executive officers in November 2018, awarding him three-year service-based vesting RSUs covering 35,053 shares and performance-based vesting RSUs covering 35,053 shares at target-level performance (with possible overachievement at 200% of target).  In addition, the Restated Agreement provides for the grant to Mr. Jensen of a retention and long-term incentive equity award in the form of RSUs covering 128,000 shares subject to three-year service-based vesting.  </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In consideration of the Company&#8217;s entering into the Restated Agreement with him, and in order to facilitate a smooth management succession process in the future, Mr. Jensen agreed to provide up to 12 months of continued consulting services to the Company following such time as he ceases to be its president and chief executive officer.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing summary of the Restated Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement which will be filed as an exhibit to the Company's next periodic report.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, at its January 8, 2019 meeting, the Board approved the grant of certain RSUs to Mr. Jensen and other executive officers, who elected to receive RSUs rather than cash in satisfaction of phantom awards granted during fiscal year 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.0078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:90%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="ex991q2revenuerelease.htm"><font style="font-family:inherit;font-size:10pt;">Press Release issued by the Company on January 9, 2019, announcing its preliminary revenue results for the three and six months ended December 31, 2018.</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: January 10, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:justify;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION</font></div><div style="padding-bottom:2px;padding-top:2px;text-align:justify;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="padding-bottom:2px;padding-top:2px;text-align:justify;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By: </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Steven R. Fife</font></div><div style="padding-bottom:2px;padding-top:2px;text-align:justify;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name: Steven R. Fife</font></div><div style="padding-bottom:2px;padding-top:2px;text-align:justify;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991q2revenuerelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sc952b18ddf9b45b1b040b152afc0b070"></a></div><div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;"><img src="logoa13.jpg" alt="logoa13.jpg" style="height:62px;width:297px;"></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:15pt;"><font style="font-family:Arial;font-size:15pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:15pt;"><font style="font-family:Arial;font-size:15pt;font-weight:bold;">LifeVantage Reports Record Second Quarter Preliminary Revenue</font></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Q2 preliminary revenue of approximately $58 million represents the highest quarterly revenue in the company&#8217;s history</font></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Revenue increased approximately 17% year over year and 4% sequentially</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Salt Lake City, UT, January 9, 2019, </font><font style="font-family:Arial;font-size:10pt;">(GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) today announced preliminary revenue for the fiscal 2019 second quarter and six month period ended December 31, 2018. </font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Preliminary revenue for the second quarter of fiscal 2019 increased approximately 17% to $58 million, compared to $50 million in the prior year period. Preliminary revenue for the first six months of fiscal 2019 increased approximately 15% to $114 million compared to $99 million in the prior year period.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8220;We are proud to report the highest level of quarterly revenue in the Company&#8217;s history,&#8221; stated LifeVantage President and Chief Executive Officer Darren Jensen. &#8220;The second quarter strength reflected a strong response to the launch of our TrueScience Hair Care System and broad based growth across our global footprint, particularly in Taiwan and the United States, reflecting the success of our 2019 initiatives.&#8221;</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company is releasing preliminary second quarter fiscal 2019 revenue in advance of its participation and presentation at the ICR Conference on January 14-16, 2019. The Company does not intend to release preliminary quarterly revenue in the future. </font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About LifeVantage Corporation</font><font style="font-family:Arial;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including Protandim&#174;, a line of scientifically-validated dietary supplements; TrueScience&#174;, a line of Nrf2 infused skin care and hair care products; Petandim&#8482; for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio&#174; Smart Energy Drink mixes; PhysIQ&#8482;, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit </font><font style="font-family:Arial;font-size:10pt;color:#0563c1;text-decoration:underline;">www.lifevantage.com</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe", "hopes", "intends", "estimates", "expects", "projects", "plans", "anticipates", "look forward to", "goal", &#8220;may be&#8221;, and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding the benefits of our key initiatives, future growth and expected financial performance. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to </font></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investor Relations Contact:</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Scott Van Winkle </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Managing Director, ICR </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(617) 956-6736</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">scott.vanwinkle@icrinc.com</font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logoa13.jpg
<TEXT>
begin 644 logoa13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  X 0H# 2(  A$! Q$!_\0
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M&\'ZAH-TQA2Z3"RJ,E'!RK?@0.*PO@C\(X/A#X7?3A=?;KN>4S3W&S:"<8
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M<_\ #,?PW_Z%N+_O])_\56Y9_!OPA8^$[SPU#I")HMY)YLUKYCX9L@YSG/\
M".A[5WSQ>5PJQKX>$U)23UMM>[/%HY;G]3#SPF+JP<'!Q5K]K+H>._L3_P#(
MF^(?7[8/_0!7F?P,_P"3GI/^OJ\_DU?7_@OX=Z!\/;.XM=!L%L(+A_,E569M
MS8QG))K,T/X,>#_#OB8^(-.T=+?5MSO]H$CDY?.XX)QSD_G6SSFBZN+J6?[U
M67W=3G7#.*6'R^ES*]"5WOWOIH?,/[6?@N[\,_$J#Q6MK]ITV^$;.77,8D0
M;&]B #[\UUGAGXH? W5=(2;5/#]EI-\%'F6\ECO^;'.TJ"",_2OIS6-%L?$&
MGRV6HVL5Y:2C#PS(&5A[@UY?>?LK?#JZNO._L5H1G)CCN'"'\,\?A54<VPU;
M#4Z&+YTX:)Q?3S)Q/#>.PN.JXO+N24:FKC-7L_(H_!/QK\/O%7B?5(/!V@KI
MUQ:P#S+P6ZQ>8I;H,<XR >:^)O\ @J7\*9/"OQ*\/?$;3@T46KHMO<R1J1LN
M8<%&+#N5P!_NFOT?\&_#?PY\/X9(]!TJ'3Q( '= 2[8]6.2?SJO\3?A3X5^,
M7AO^P?%^D1:QI?FK.()&9<.N<,"I!!Y/0UY<<?2HXWVU*[AMJ[NQ]9A<!76!
M5'$<O/O[JLC\B-'U/6/VW?VJ/"ZZE#(B7*VT-U&A++#;VZ RD'H Q!/U:O>/
M^"LLVOV-UX"TV,20^#EMY?+CC)$1N5( # <<)C /J<5]K_"[]E_X9_!G7YM:
M\'^&(-'U.:#[,]PDLCDQD@D?,QQR!T]*[7QOX!\._$C0I=%\3Z/:ZUIDG)M[
MN,,N1T(]#[BMZF:4OK-.<(^Y#H;PP$_83C*7O2/SCT3_ (95A_9?U!K,:7_P
MG+Z%("-0\PWGV_R2/E!X'S],<8Q7.?\ !.?/_")_''/WO^$<.<^NR2OL>Y_X
M)S? >ZNFF_X1*2+=R8X[Z8+^&6/\Z]&^'?[,GPV^%.F:Q8>%_#,.FV^L0&VO
MMLLCM/'@C:2S$XP3T]:NIF5#V4X1<FY-/7IJ3#!5>>,G9670_.__ ()2?\G"
M>(/^Q?D_]'QU[]_P5GX^#/A0?]1M?_13U](?"W]E_P"&GP7\03ZWX.\,Q:-J
M4]N;62>.:1R8RP8KAF(Z@'\*W?BK\&/!_P ;-'M-+\9:-'K5C:S_ &B&*1W3
M;)@C.5(/0USU,PISQ\<4D[(VA@YQPKH7U9^:WBC2+K4O^"7_ (4N;>%Y8K'7
MVGG9%)"(9)%W''098#/O73?L1_MO>!/@?\'Y?"?BN+4(K^WO))[=[2#S5N%D
M(P <C!!R.>,8YK]!_"OP=\'^"_ !\$Z5H5O#X699$;39,RQLKDE@=Y)(.3UK
MQYO^"=WP+;6O[0'A)E&X/]E6]F$(8'((7=^F<5M_:&&K4YTJT79RNK&7U.M3
MG&I3:NE9GQ+_ ,%-M8U75?CQH;:BUU_PC4FDV\^GQ,3Y95CF0J.F_)(/?@=L
M5V/QH'[+4'[,^JCX?_V3_P )8UK#]CW>8;WS-Z[L[NAQNSV]*_0CQ_\ !GP5
M\4]!@T;Q5X=L]9T^W4+!'.GS0X 'R,/F7@#H1TKQO_AW'\!Q<&7_ (1*3&<^
M7]OFV_3[V?UJJ.98=4Z<)<T>3MU]0J8*JYSDK/F[]#XV_97^$=]\;/V._BYX
M;TG#:PNI6]Y9QG_EI)&F[9[%@"![D5G_ +&/[8L'[*JZ_P"#_&NAW_\ 9L]T
M;@B","YM;C 5U9&(RI '?(([YK]-OAO\'_!?P+T"_M?!VA0Z+:2G[1/'"S,9
M&5>I+$G..*^2M7_:H_9/^-6_4/'.A0VNL*QB?^T-,=ICM)'^MB!W#CC)K6.,
M6,=6+I.4&[Z;HR>&>'4)*:C)'SC^WE^U;X1_:6'A2+PK;ZA&-':X::2^B6,,
M) H&T D_PG.<=JZ3]HCX1ZQXL_8Q^"WC32K=[N#0-.>"_BA0LZ1R-Q+@?PJ1
M@^F0:\N_:N\9?"[QYXF\/^'?@KX4CL[&VW(UW;6[++J$\A 5 IRQ"XXSW)XQ
M7ZS? 7P"_@/X'^#_  OJ,"F>TTN*&[@D 8>85RZD>@)(_"NK$UXX&A0=.+5G
ML]S"A2>*JU.=WNMSX"_9S_:"_9JNO NFZ5\2? VDZ3XAL8%@EU)M,\^*\V\"
M3*J2&(Y((ZYYKVGX3_&C]F?Q5\</#WACP!X%M9];F,DUKK%OIBP1PM'&SD@M
MALX4@<=37J7BS]@3X(^,-0EO9_!\=A<2MN<Z=/) I.<GY =H_ =ZZ_X6_LK_
M  N^#.H+J'A7PE:V&IJI5;Z1GFF4$8.&<G&>>E>77Q>$J*4HN=WTOH>A2PU>
M#47RV7WC_ ?QFNO%WCS4M"DTPQ1V_P#$H.Z,=MV>#GD''W3@<YKUFJT-A;V\
MTLT4$<<TGWY%0!F^I[U9KY^<HR=XJQZT$TO>85')&LJ,CJ'5A@JPSG-%%06?
M//CS]D.Q_P"$BD\7?"[7+CX8>,&^:6334!L+T^D]M]TY]0 ><\FLW1?V1M3\
M=:U;:U\;_&,WQ#GM6#6FB01FUTN$@Y#-$I_>-[MQ[&BBNI8RLHVO\^OW[G/]
M7IWYK?Y?<?2&FZ;::/8PV=A;0V=I"H2*"",(B*.@  P!5NBBN1N[U.C86BBB
MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!&R+(I5AN4C
M!4]Z^>/$_P"P%\#_ !5JUQJ-QX.6TN)V+R"QN)(4+'J0H.!^ %%%;4JU2BVZ
M<FO0RE3A47OJYTWPK_9'^%7P:U0ZGX9\*6\.I\;;VZ9IY8_]PN3M/N,&O8U-
;%%34J3JOFF[LJ,(TU:*L.HHHK,L**** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
